medigraphic.com
ISSN 0001-0944 (Impreso)
Órgano Oficial de la Asociación Dental Mexicana

2008, Número 1

<< Anterior Siguiente >>

Rev ADM 2008; 65 (1)


Manejo clínico-farmacológico del dolor dental

Pozos GAJ, Aguirre BP, Pérez UJ

Idioma: Español
Referencias bibliográficas: 86
Paginas: 36-43
Archivo PDF: 101.20 Kb.


RESUMEN

En la práctica odontológica es frecuente el tratamiento farmacológico con analgésicos para mitigar el dolor en pacientes que han sido sometidos a algún procedimiento odontológico mayor, con el fin de prevenir o disminuir el dolor provocado con el procedimiento. Sin embargo, a la fecha no se puede hablar de un manejo estandarizado para todo tipo de pacientes y la investigación en la búsqueda del mejor tratamiento farmacológico es continua. Se presentan en esta revisión los aspectos fundamentales del dolor, las características del dolor dental, los diferentes fármacos y estrategias de manejo del dolor que se han utilizado en diferentes estudios clínicos y algunas recomendaciones.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy and pathophysiologic approach. 3rd ed. USA: Appleton & Lange; 1996: 1259-1278.

  2. Casey KL. Forebrain mechanisms of nociception and pain: analysis through imaging. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96: 7668-7674.

  3. Mehlisch DR. The efficacy of combination analgesic therapy in relieving dental pain. JADA 2002; 133: 861-871.

  4. Ciancio SG, Bourgault PC. Farmacología clínica para odontólogos. Manual Moderno. México, 1990.

  5. Gordon SM, Dionne RA, Brahim J, Jabir F, Dubner R. Blockade of peripheral neuronal barrage reduces postoperative pain. Pain 1997; 70: 209-215.

  6. Cooper SA, Precheur H, Rauch D, Rosenheck A, Ladov M, Engel J. Evaluation of oxycodone and acetaminophen in treatment of postoperative dental pain. Oral Surg Oral Med Oral Pathol 1980; 50: 496-501.

  7. McQuay HJ, Moore RA. Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review. Health Technol Assess 1998; 2: 1-236.

  8. Mehlisch DR, Frakes LA. A controlled comparative evaluation of acetaminophen and aspirin in the treatment of postoperative pain. Clin Ther 1984; 7: 89-97.

  9. Skoglund LA, Skjelbred P, Fyllingen G. Analgesic efficacy of acetaminophen 1,000 mg, acetaminophen 2,000 mg, and the combination of acetaminophen 1,000 mg and codeine phosphate 60 mg versus placebo in acute postoperative pain. Pharmacotherapy 1991; 11(5): 364-369.

  10. Mehlisch DR, Sollecito WA, Helfrick JF, Leibold DG, Markowitz R, Schow CE Jr, Shultz R, Waite DE. Multicenter clinical trial of ibuprofen and acetaminophen in the treatment of postoperative dental pain. JADA 1990; 121: 257-263.

  11. Dionne RA, Berthold CW. Therapeutic uses of non-steroidal anti-inflammatory drugs in dentistry. Crit Rev Oral Biol Med 2001; 12: 315-330.

  12. Jain AK, Ryan JR, McMahon FG, Kuebel JO, Walters PJ, Noveck C. Analgesic efficacy of low-dose ibuprofen in dental extraction pain. Pharmacotherapy 1986; 6: 318-322.

  13. McQuay HJ, Carroll D, Guest PG, Robson S, Wiffen PJ, Juniper RP. A multiple dose comparison of ibuprofen and dihydrocodeine after third molar surgery. Br J Oral Maxillofac Surg 1993; 31: 95-100.

  14. Seymour RA, Ward-Booth P, Kelly PJ. Evaluation of different doses of soluble ibuprofen and ibuprofen tablets in postoperative dental pain. Br J Oral Maxillofac Surg 1996; 34: 110-114.

  15. Vogel RI, Desjardins PJ, Major KV. Comparison of presurgical and immediate postsurgical ibuprofen on postoperative periodontal pain. J Periodontol 1992; 63: 914-918.

  16. Ngan P, Wilson S, Shanfeld J, Amini H. The effect of ibuprofen on the level of discomfort in patients undergoing orthodontic treatment. Am J Orthod Dentofacial Orthop 1994; 106: 88-95.

  17. Torabinejad M, Dorn SO, Eleazer PD, Frankson M, Jouhari B, Mullin RK, Soluti A. Effectiveness of various medications on postoperative pain following root canal obturation. J Endod 1994; 20: 427-431.

  18. Cooper SA. Ketoprofen in oral surgery pain: a review. J Clin Pharmacol 1988; 28(12 Suppl): S40-S46.

  19. Dionne RA. Additive analgesic effects of oxicodone and ibuprofen in the oral surgery model. Am J Oral Maxillofac Surg 1999; 57: 673-678.

  20. Dionne RA, Snyder J, Hargreaves KM. Analgesic efficacy of flurbiprofen in comparison with acetaminophen, acetaminophen plus codeine, and placebo after impacted third molar removal. J Oral Maxillofac Surg 1994; 52: 919-924.

  21. Troullos ES, Hargreaves KM, Butler DP, Dionne RA. Comparison of nonsteroidal antiinflammatory drugs, ibuprofen and flurbiprofen, with methylprednisolone and placebo for acute pain, swelling, and trismus. J Oral Maxillofac Surg 1990; 48: 945-952.

  22. Flath RK, Hicks ML, Dionne RA, Pelleu GB Jr. Pain suppression after pulpectomy with preoperative flurbiprofen. J Endod 1987; 13: 339-347.

  23. Stanski DR, Cherry C, Bradley R, Sarnquist FH, Yee JP. Efficacy and safety of single doses of intramuscular ketorolac tromethamine compared with meperidine for postoperative pain. Pharmacotherapy 1990; 10(6 (Pt 2): 40S-44S.

  24. Spindler JS, Mehlisch D, Brown CR. Intramuscular ketorolac and morphine in the treatment of moderate to severe pain after major surgery. Pharmacotherapy 1990; 10(6 (Pt 2): 51S-58S.

  25. Penniston SG, Hargreaves KM. Evaluation of periapical injection of ketorolac for management of endodontic pain. J Endod 1996; 22: 55-59.

  26. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, Isakson PC, Geis GS. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998; 41: 1591-1602.

  27. Hirata T, Ukawa H, Yamakuni H, Kato S, Takeuchi K. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs. Br J Pharmacol 1997; 122: 447-454.

  28. Chan CC, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 1995; 274: 1531-1537.

  29. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 23(343): 1520-1528.

  30. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284: 1247-1255.

  31. Gilron I, Milne B, Hong M. Cyclooxygenase-2 inhibitors in postoperative pain management: current evidence and future directions. Anesthesiology 2003; 99: 1198-1208.

  32. Cicconetti A, Bartoli A, Ripari F, Ripari A. COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 139-146.

  33. May N, Epstein J, Osborne B. Selective COX-2 inhibitors: a review of their therapeutic potential and safety in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 399-405.

  34. Steinmeyer J. Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. Arthritis Res 2000; 2: 379-385.

  35. Moore PA, Hersh EV. Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice. JADA 2001; 132: 451-456.

  36. Weaver AL. Rofecoxib: clinical pharmacology and clinical experience. Clin Ther 2001; 23: 1323-1338.

  37. Malmstrom K, Daniels S, Kotey P, Seidenberg BC, Desjardins PJ. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo and active-comparator-controlled clinical trial. Clin Ther 1999; 21: 1653-1663.

  38. Doyle G, Jayawardena S, Ashraf E, Cooper SA. Efficacy and tolerability of nonprescription ibuprofen versus celecoxib for dental pain. J Clin Pharmacol 2002; 42: 912-919.

  39. Khan AA, Brahim JS, Rowan JS, Dionne RA. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. Clin Pharmacol Ther 2002; 72: 44-49.

  40. Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W, Porras A, Wittreich J, Seibold JR, De Schepper P, Mehlisch DR, Gertz BJ. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther 1999; 65: 336-447.

  41. Gopikrishna V, Parameswaran A. Effectiveness of prophylactic use of rofecoxib in comparison with ibuprofen on postendodontic pain. J Endod 2003; 29: 62-64.

  42. Desjardins PJ, Shu VS, Recker DP, Verburg KM, Woolf CJ. A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain. Anesthesiology 2002; 97: 565-573.

  43. Haas DA. An update on analgesics for the management of acute postoperative dental pain. J Can Dent Assoc 2002; 68: 476-482.

  44. Valle M, Garrido MJ, Pavón JM, Calvo R, Trocóniz IE. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-Desmethyltramadol and (-)-O-Desmethyltramadol, in rats. J Pharmacol Exp Ther 2000; 293: 646- 653.

  45. Garrido MJ, Valle M, Campanero MA, Calvo R, Trocóniz IF. Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-Desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-Desmethyltramadol, in rats. J Pharmacol Exp Ther 2000; 293: 352-359.

  46. Miranda HF, Pinardi G. Antinoception, tolerance and physical dependence comparison between morphine and tramadol. Pharmacol Bio Behavior 1998; 61: 357-360.

  47. Moore RA, McQuay HJ. Single-patient data meta-analysis of 3,453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 1997; 69: 287-294.

  48. Silvasti M, Tarkkila P, Tuominen M, Svartling N, Rosenberg PH. Efficacy and side effects of tramadol versus oxycodone for patient-controlled analgesia after maxillofacial surgery. Eur J Anaesthesiol 1999; 16: 834-839.

  49. Moore PA, Crout RJ, Jackson DL, Schneider LG, Graves RW, Bakos L. Tramadol hydrochloride: analgesic efficacy compared with codeine, aspirin with codeine, and placebo after dental extraction. J Clin Pharmacol 1998; 38: 554-560.

  50. Broome IJ, Robb HM, Raj N, Girgis Y, Wardall GJ. The use of tramadol following day-case oral surgery. Anaesthesia 1999; 54: 289-292.

  51. Collins M, Young I, Sweeney P, Fenn GC, Stratford ME, Wilson A, Harris M. The effect of tramadol on dento-alveolar surgical pain. Br J Oral Maxillofac Surg 1997; 35: 54-58.

  52. Roelofse JA, Payne KA. Oral tramadol: analgesic efficacy in children following multiple dental extractions. Eur J Anaesthesiol 1999; 16: 441-447.

  53. Pozos-Guillen AJ, Aguirre-Bañuelos P, Arellano-Guerrero A, Hoyo-Vadillo C, Perez-Urizar J. Evidence of self-sinergism in the antinociceptive effect of tramadol in rats. Proc West Pharmacol Soc 2004; 47: 117-119.

  54. Altunkaya H, Ozer Y, Kargi E, Ozkocak I, Hosnuter M, Demirel CB, Babuccu O. The postoperative analgesic effect of tramadol when used as subcutaneous local anesthetic. Anesth Analg 2004; 99: 1461-1464.

  55. Phero JC, Becker D. Rational use of analgesic combinations. Dent Clin North Am 2002; 46: 691-705.

  56. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg 1993; 77: 1048-1056.

  57. Cooper SA, Beaver WT. A model to evaluate mild analgesics in oral surgery outpatients. Clin Pharmacol Ther 1976; 20: 241-250.

  58. Norholt SE. Treatment of acute pain following removal of mandibular third molars. Use of the dental pain model in pharmacological research and development of a comparable animal model. Int J Oral Maxillofac Surg 1998; 27(Suppl 1): 1-41.

  59. Hubbard RC, Jasper DR, Nugent MJ, Charleson S, Cromlish W, Either D. SC-58635. A highly selective inhibitor of COX-2, is an effective analgesic in an acute post-surgical pain model. J Invest Med 1996; 44: 293A.

  60. Gottesdiener K, Mehlish DR, Huntington M, Yuan WY, Brown P, Gertz B. Efficacy and tolerability of the specific cyclooxygenase-2 inhibitor DFP compared with naproxen sodium in patients with postoperative dental pain. Clin Ther 1999; 21: 1301-1312.

  61. Norholt SE, Sindet-Pedersen S, Bugge C, Branebjerg PE, Ersboll BK, Bastian HL. A randomized, double-blind, placebo-controlled, dose-response study of the analgesic effect of lornoxicam after surgical removal of mandibular third molars. J Clin Pharmacol 1995; 35: 606-614.

  62. Urquhart E. Analgesic agents and strategies in the dental pain model. J Dent 1994; 22: 336-341.

  63. Averbuch M, Katzper M. Severity of baseline pain and degree of analgesia in the third molar post-extraction dental pain model. Anesth Analg 2003; 97: 163-167.

  64. Seymour RA, Hawkesford JE, Sykes J, Stillings M, Hill CM. An investigation into the comparative efficacy of soluble aspirin and solid paracetamol in postoperative pain after third molar surgery. Br Dent J 2003; 194: 153-157.

  65. Barden J, Edwards JE, McQuay HJ, Moore RA. Pain and analgesic response after third molar extraction and other postsurgical pain. Pain 2004; 107: 86-90.

  66. Van Aken H, Thys L, Veekman L, Buerkle H. Assessing analgesia in single and repeated administrations of propacetamol for postoperative pain: comparison with morphine after dental surgery. Anesth Analg 2004; 98: 159-165.

  67. Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC. Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery. J Oral Maxillofac Surg 2003; 61: 1030-1037.

  68. Dionne RA, Gordon SM, Rowan J, Kent A, Brahim JS. Dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation. J Oral Maxillofac Surg 2003; 61: 997-1003.

  69. Bjornsson GA, Haanaes HR, Skoglund LA. Naproxen 500 mg bid versus acetaminophen 1,000 mg qid: effect on swelling and other acute postoperative events after bilateral third molar surgery. J Clin Pharmacol 2003; 43: 849-858.

  70. Fricke JR Jr, Karim R, Jordan D, Rosenthal N. A double-blind, single-dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets, and placebo after oral surgery. Clin Ther 2002; 24: 953-968.

  71. Daniels SE, Desjardins PJ, Talwalker S, Recker DP, Verburg KM. The analgesic efficacy of valdecoxib vs oxycodone/acetaminophen after oral surgery. JADA 2002; 133: 611-621.

  72. Frank AJ, Moll JM, Hort JF. A comparison of three ways of measuring pain. Rheumatol Rehabil 1982; 21: 211-217.

  73. Huskisson EC. Measurement of pain. Lancet 1974; 2(7889): 1127-1131.

  74. Wallenstein SL, Heidrich G 3rd, Kaiko R, Houde RW. Clinical evaluation of mild analgesics: the measurement of clinical pain. Br J Clin Pharmacol 1980; 10 Suppl 2: 319S-327S.

  75. Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G. Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 1983; 34: 234-239.

  76. Littman GS, Walker BR, Schneider BE. Reassement of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther 1985; 38: 16-23.

  77. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 1997; 72: 95-97.

  78. Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anesth 2001; 48: 1000-1010.

  79. Dionne RA. Preemptive vs preventive analgesia: which approach improves clinical outcomes? Compend Contin Educ Dent 2000; 21: 51-54.

  80. Beilin B, Bessler H, Mayburd E, Smirnov G, Dekel A, Yardeni I, Shavit Y. Effects of preemptive analgesia on pain and cytokine production in the postoperative period. Anesthesiology 2003; 98: 151-155.

  81. Carr DB. Preempting the memory of pain. JAMA 1998; 279: 1114-1115.

  82. Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia II: recent advances and current trends. Can J Anesth 2001; 48: 1091-1101.

  83. Dionne RA, Gordon SM, Tahara M, Rowan J, Troullos E. Analgesic efficacy and pharmacokinetics of ketoprofen administered into a surgical site. J Clin Pharmacol 1999; 39: 131-138.

  84. Dionne RA, Lepinski AM, Gordon SM, Jaber L, Brahim JS, Hargreaves KM. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther 2001; 70: 66-73.

  85. Kehlet H, Werner M, Perkins F. Balanced analgesia. What is it and what are its advantages in postoperative pain? Drugs 1999; 58: 793-797.

  86. Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther 2001; 26: 257-264.




2020     |     www.medigraphic.com